-
1.
公开(公告)号:US20200215297A1
公开(公告)日:2020-07-09
申请号:US16722328
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi
IPC: A61M21/02
Abstract: Systems and methods to mitigate negative effects of a drug in a treatment of a mental health condition include administering a drug to a subject in a therapy session; determining effects of the drug, the effects being counterproductive to the therapy session; and providing tactile stimulation to a subject with a stimulation device that generates transcutaneous vibratory output to be applied to a portion of a body of the subject during the therapy session, wherein the transcutaneous vibratory output is selected to reduce the counterproductive effects of the drug.
-
公开(公告)号:US20220001135A1
公开(公告)日:2022-01-06
申请号:US17480422
申请日:2021-09-21
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi
IPC: A61M21/02 , A61H1/00 , G16H20/00 , A61H23/00 , G16H20/30 , G16H40/67 , G16H10/60 , G16H50/30 , G16H20/70 , A61B5/00 , G05B19/416
Abstract: Certain pet products, such as collar, halters, pet beds, and the like, may be adapted to provide transcutaneous vibratory output. A device adapted to be worn by a non-human animal may include i) at least one of a collar or a harness structured to fit the non-human animal; and ii) at least one transducer located at least partially within the at least one collar or harness and structured to deliver a transcutaneous vibratory output to the non-human animal, the transcutaneous vibratory output having variable parameters comprising a perceived pitch, a perceived beat, and a perceived intensity.
-
3.
公开(公告)号:US10974020B2
公开(公告)日:2021-04-13
申请号:US16722328
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi
IPC: A61M21/02 , G16H20/70 , A61H1/00 , G16H20/00 , A61H23/00 , G16H20/30 , G16H40/67 , G16H10/60 , G16H50/30 , A61B5/00 , G05B19/416 , A61M21/00
Abstract: Systems and methods to mitigate negative effects of a drug in a treatment of a mental health condition include administering a drug to a subject in a therapy session; determining effects of the drug, the effects being counterproductive to the therapy session; and providing tactile stimulation to a subject with a stimulation device that generates transcutaneous vibratory output to be applied to a portion of a body of the subject during the therapy session, wherein the transcutaneous vibratory output is selected to reduce the counterproductive effects of the drug.
-
公开(公告)号:USD910862S1
公开(公告)日:2021-02-16
申请号:US29697039
申请日:2019-07-03
Applicant: Apollo Neuroscience, Inc.
-
公开(公告)号:US20220080150A1
公开(公告)日:2022-03-17
申请号:US17533880
申请日:2021-11-23
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi , Raymond G. Pelletier
IPC: A61M21/02 , A61H1/00 , G16H20/00 , A61H23/00 , G16H20/30 , G16H40/67 , G16H10/60 , G16H50/30 , G16H20/70 , A61B5/00 , G05B19/416
Abstract: Delivering vibratory therapy to a user may include using a system with a first transducer adapted to emit a first transcutaneous vibratory output; a second transducer adapted to emit a second transcutaneous vibratory output; and a processor in electronic communication with a user interface, the first transducer, and the second transducer, wherein the user interface accepts a user target state. The processor may be programmed to (i) generate a first transcutaneous vibratory output pattern comprising a first perceived pitch, a first perceived beat, and a first intensity; (ii) generate a second transcutaneous vibratory output pattern comprising a second perceived pitch, a second perceived beat, and a second intensity; (iii) cause the first transducer to emit a first transcutaneous vibratory output based on the first transcutaneous vibratory output pattern; and (iv) cause the second transducer to emit a second transcutaneous vibratory output based on the second transcutaneous vibratory output pattern.
-
公开(公告)号:US11260198B2
公开(公告)日:2022-03-01
申请号:US16722299
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi , Raymond G. Pelletier
IPC: A61M21/02 , A61H1/00 , G16H20/00 , A61H23/00 , G16H20/30 , G16H40/67 , G16H10/60 , G16H50/30 , G16H20/70 , A61B5/00 , G05B19/416 , A61M21/00
Abstract: Systems and methods of assisting a subject to reach a target state include obtaining input of the target state of the subject; and generating a transcutaneous vibratory output to be applied to a portion of a body of the subject to assist the subject in achieving the target state, the transcutaneous vibratory output having variable parameters comprising a perceived pitch, a perceived beat, and a perceived intensity wherein the step of generating the transcutaneous vibratory output further comprises the step of modifying the variable parameters to correspond to the target state.
-
公开(公告)号:US20200215298A1
公开(公告)日:2020-07-09
申请号:US16722345
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi
Abstract: Systems and methods of delivering a therapeutic session to affect a mental or an emotional state of a user include providing a wearable stimulation device having a transducer adapted to generate tactile transcutaneous vibratory output; with a user interface, obtaining data regarding an event to be experienced by the user; communicating the data regarding an event to be experienced by the user to a computer processor; with the computer processor, creating a therapeutic session parameters comprising the following steps: assigning a set of contiguous output segments for the event, and based on the event, assigning a perceived pitch of transcutaneous vibratory output and a perceived beat of transcutaneous vibratory output to each output segment; sending, from the computer processor, the therapeutic session parameters to the transducer; and generating, with the transducer, transcutaneous vibratory output for the therapeutic session based on the therapeutic session parameters.
-
公开(公告)号:US11872351B2
公开(公告)日:2024-01-16
申请号:US16722345
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi , Raymond G. Pelletier
IPC: A61M21/02 , A61H23/00 , G16H20/00 , A61H1/00 , G16H20/30 , G16H40/67 , G16H10/60 , G16H50/30 , G16H20/70 , A61B5/00 , G05B19/416 , A61M21/00
CPC classification number: A61M21/02 , A61B5/4812 , A61H1/00 , A61H23/00 , G05B19/416 , G16H10/60 , G16H20/00 , G16H20/30 , G16H20/70 , G16H40/67 , G16H50/30 , A61H2201/165 , A61H2201/5005 , A61H2201/5007 , A61H2201/5023 , A61H2230/045 , A61H2230/085 , A61H2230/105 , A61H2230/203 , A61H2230/305 , A61H2230/425 , A61M2021/0016 , A61M2021/0022 , A61M2021/0044 , A61M2205/05 , A61M2205/3303 , G05B2219/37032
Abstract: Systems and methods of delivering a therapeutic session to affect a mental or an emotional state of a user include providing a wearable stimulation device having a transducer adapted to generate tactile transcutaneous vibratory output; with a user interface, obtaining data regarding an event to be experienced by the user; communicating the data regarding an event to be experienced by the user to a computer processor; with the computer processor, creating a therapeutic session parameters comprising the following steps: assigning a set of contiguous output segments for the event, and based on the event, assigning a perceived pitch of transcutaneous vibratory output and a perceived beat of transcutaneous vibratory output to each output segment; sending, from the computer processor, the therapeutic session parameters to the transducer; and generating, with the transducer, transcutaneous vibratory output for the therapeutic session based on the therapeutic session parameters.
-
公开(公告)号:US11534571B2
公开(公告)日:2022-12-27
申请号:US16722350
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi , Raymond G. Pelletier
IPC: A61M21/02 , A61B5/00 , A61H1/00 , G16H20/00 , A61H23/00 , G16H20/30 , G16H40/67 , G16H10/60 , G16H50/30 , G16H20/70 , G05B19/416 , A61M21/00
Abstract: Systems and methods of treating a sleep disorder of a subject include providing a therapeutic stimulation device comprising a transducer configured to emit transcutaneous vibratory output to a body part of the subject; generating physiological data with a worn sensor and providing it to a processor; providing a stimulation pattern for transcutaneous vibratory output to be emitted by the transducer comprising a perceived pitch, a perceived beat, and an intensity; causing the transducer to emit the transcutaneous vibratory output in the stimulation pattern; determining if the subject is in a pre-sleep state or a sleep state based on the physiological data; and altering the stimulation pattern based on determining the subject is in at least one of a pre-sleep state or a sleep state comprising at least one of (i) reducing a frequency of the perceived pitch, (ii) increasing an interval of the perceived beat, or (iii) reducing the intensity.
-
公开(公告)号:US20200219615A1
公开(公告)日:2020-07-09
申请号:US16722350
申请日:2019-12-20
Applicant: Apollo Neuroscience, Inc.
Inventor: David Mayer Lowell Rabin , Kathryn Fantauzzi
IPC: G16H40/67 , G05B19/416 , G16H20/70 , G16H50/30 , G16H10/60 , G16H20/30 , A61B5/00 , A61M21/02 , A61M21/00
Abstract: Systems and methods of treating a sleep disorder of a subject include providing a therapeutic stimulation device comprising a transducer configured to emit transcutaneous vibratory output to a body part of the subject; generating physiological data with a worn sensor and providing it to a processor; providing a stimulation pattern for transcutaneous vibratory output to be emitted by the transducer comprising a perceived pitch, a perceived beat, and an intensity; causing the transducer to emit the transcutaneous vibratory output in the stimulation pattern; determining if the subject is in a pre-sleep state or a sleep state based on the physiological data; and altering the stimulation pattern based on determining the subject is in at least one of a pre-sleep state or a sleep state comprising at least one of (i) reducing a frequency of the perceived pitch, (ii) increasing an interval of the perceived beat, or (iii) reducing the intensity.
-
-
-
-
-
-
-
-
-